Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A melanoma octamer binding protein is responsive to differentiating agents.

R A Sturm1, F Bisshop, H Takahashi

  • 1Centre for Molecular Biology and Biotechnology, University of Queensland, Australia.

Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|October 1, 1991
PubMed
Summary

Researchers identified two melanoma octamer binding proteins (Oct-M1 and Oct-M2) in human melanocytes and melanoma cells. Oct-M2 was found only in metastatic tumor cell lines, suggesting its role in melanoma progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of dolutegravir/lamivudine in virologically suppressed female participants: week 48 data from the pooled TANGO and SALSA studies.

HIV medicine·2024
Same author

HIV in practice: current approaches and challenges in the diagnosis, treatment and management of HIV infection in Australia.

HIV medicine·2018
Same author

Acinar cell carcinoma of the pancreas with elevated serum alpha-fetoprotein levels: a case report and a review of 28 cases reported in Japan.

Gastroenterologia Japonica·1992
Same author

[Coagulation and fibrinolysis in pregnancy].

Rinsho byori. The Japanese journal of clinical pathology·1992
Same author

[Elevated production of GM-CSF by peripheral blood mononuclear cells stimulated with mite antigens in children with bronchial asthma].

Arerugi = [Allergy]·1992
Same author

[A survey of body temperatures in the elderly and the thermal environment in nursing homes].

[Nihon koshu eisei zasshi] Japanese journal of public health·1992

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biochemistry

Background:

  • The octamer control sequence (ATGCAAAT) is crucial for regulating gene expression in various cell types.
  • Understanding proteins that bind to this sequence is vital for deciphering gene regulation in normal and cancerous cells, particularly in melanoma.

Purpose of the Study:

  • To identify and characterize novel octamer binding proteins in human melanocytes and melanoma cell lines.
  • To investigate the differential expression and regulation of these proteins in relation to melanoma progression and differentiation.

Main Methods:

  • Proteomic analysis of human melanocytes and melanoma cell lines to identify proteins interacting with the octamer control sequence.
  • Comparative analysis of protein expression in metastatic versus non-metastatic melanoma cell lines.

Related Experiment Videos

  • Functional assays to assess the activity of identified proteins under different cellular conditions (e.g., presence of depigmenting or differentiating agents).

    • Main Results:

    • Two distinct melanoma octamer binding proteins, designated Oct-M1 and Oct-M2, were identified.
    • Oct-M2 expression was exclusively observed in cell lines derived from tumor metastases.
    • Oct-M1 activity was modulated by agents affecting pigmentation: enhanced by dithiothreitol (depigmenting) and reduced by butyric acid and dimethyl sulfoxide (differentiating/pigment-inducing).

    Conclusions:

    • The identification of Oct-M1 and Oct-M2 provides new insights into the molecular mechanisms of melanoma.
    • The restricted expression of Oct-M2 in metastatic cell lines suggests its potential role as a biomarker or therapeutic target in advanced melanoma.
    • The differential regulation of Oct-M1 activity by pigmentation-modulating agents highlights its involvement in melanoma cell phenotype plasticity.